Coffee consumption and risk of acute myocardial infarction in Italian males

Barbara D'Avanzo, Carlo La Vecchia, Gianni Tognoni, Silvia Franceschi, Maria Grazia Franzosi, Alessandro Nobili, Luigi Santoro, Giovanni Scarsi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The relationship between coffee consumption and acute myocardial infarction (AMI) was analyzed using data from a case-control study conducted in 1988 to 1989 within the framework of the GISSI-2 trial on streptokinase versus alteplase and heparin versus no heparin in the treatment of AMI. A total of 801 male patients with AMI and 792 control subjects who were hospitalized in several Italian regions for diseases unrelated to known or potential risk factors for cardiovascular diseases were included. Compared with coffee nondrinkers, the multivariate relative risks (RRs), after allowance for age, education, body mass index, smoking habits, alcohol consumption, family history of AMI, cholesterol level, history of diabetes, and hypertension, were 0.8 (95% confidence interval (CI), 0.5 to 1.2) for consumption of one cup/d, 1.3 (95% CI, 0.9 to 2.0) for two cups/d, 1.8 (95% CI, 1.1 to 2.7) for three cups, 2.5 (95% CI, 1.5 to 4.1) for four cups, and 2.6 (95% CI, 1.6 to 4.2) for five cups or more. The trend in risk with dose was statistically significant (P <0.001). Duration of coffee consumption was not associated with the risk of AMI. The RRs for daily coffee consumption were elevated across strata of various covariates, including age, smoking habits, cholesterol level, diabetes, and hypertension, with a particularly elevated (although not significantly heterogeneous) estimate in patients younger than 50 years (RR, 5.7; 95% CI, 3.0 to 10.9 for four or more cups/d). The RR in patients who drank four or more cups of coffee per day and were current smokers was 8.1 (95% CI, 5.1 to 13.0), suggesting an unfavorable effect on the combination of cigarette smoking and high coffee intake on the risk of AMI.

Original languageEnglish
Pages (from-to)595-600
Number of pages6
JournalAnnals of Epidemiology
Volume3
Issue number6
DOIs
Publication statusPublished - 1993

Fingerprint

Coffee
Myocardial Infarction
Confidence Intervals
Smoking
Habits
Heparin
Cholesterol
Hypertension
Streptokinase
Tissue Plasminogen Activator
Alcohol Drinking
Case-Control Studies
Body Mass Index
Cardiovascular Diseases
Education

Keywords

  • Case-control study
  • coffee
  • myocardial infarction
  • risk
  • smoking

ASJC Scopus subject areas

  • Medicine(all)
  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

D'Avanzo, B., La Vecchia, C., Tognoni, G., Franceschi, S., Grazia Franzosi, M., Nobili, A., ... Scarsi, G. (1993). Coffee consumption and risk of acute myocardial infarction in Italian males. Annals of Epidemiology, 3(6), 595-600. https://doi.org/10.1016/1047-2797(93)90081-E

Coffee consumption and risk of acute myocardial infarction in Italian males. / D'Avanzo, Barbara; La Vecchia, Carlo; Tognoni, Gianni; Franceschi, Silvia; Grazia Franzosi, Maria; Nobili, Alessandro; Santoro, Luigi; Scarsi, Giovanni.

In: Annals of Epidemiology, Vol. 3, No. 6, 1993, p. 595-600.

Research output: Contribution to journalArticle

D'Avanzo, B, La Vecchia, C, Tognoni, G, Franceschi, S, Grazia Franzosi, M, Nobili, A, Santoro, L & Scarsi, G 1993, 'Coffee consumption and risk of acute myocardial infarction in Italian males', Annals of Epidemiology, vol. 3, no. 6, pp. 595-600. https://doi.org/10.1016/1047-2797(93)90081-E
D'Avanzo, Barbara ; La Vecchia, Carlo ; Tognoni, Gianni ; Franceschi, Silvia ; Grazia Franzosi, Maria ; Nobili, Alessandro ; Santoro, Luigi ; Scarsi, Giovanni. / Coffee consumption and risk of acute myocardial infarction in Italian males. In: Annals of Epidemiology. 1993 ; Vol. 3, No. 6. pp. 595-600.
@article{99854af75a17404f9edc1fb7d485f34d,
title = "Coffee consumption and risk of acute myocardial infarction in Italian males",
abstract = "The relationship between coffee consumption and acute myocardial infarction (AMI) was analyzed using data from a case-control study conducted in 1988 to 1989 within the framework of the GISSI-2 trial on streptokinase versus alteplase and heparin versus no heparin in the treatment of AMI. A total of 801 male patients with AMI and 792 control subjects who were hospitalized in several Italian regions for diseases unrelated to known or potential risk factors for cardiovascular diseases were included. Compared with coffee nondrinkers, the multivariate relative risks (RRs), after allowance for age, education, body mass index, smoking habits, alcohol consumption, family history of AMI, cholesterol level, history of diabetes, and hypertension, were 0.8 (95{\%} confidence interval (CI), 0.5 to 1.2) for consumption of one cup/d, 1.3 (95{\%} CI, 0.9 to 2.0) for two cups/d, 1.8 (95{\%} CI, 1.1 to 2.7) for three cups, 2.5 (95{\%} CI, 1.5 to 4.1) for four cups, and 2.6 (95{\%} CI, 1.6 to 4.2) for five cups or more. The trend in risk with dose was statistically significant (P <0.001). Duration of coffee consumption was not associated with the risk of AMI. The RRs for daily coffee consumption were elevated across strata of various covariates, including age, smoking habits, cholesterol level, diabetes, and hypertension, with a particularly elevated (although not significantly heterogeneous) estimate in patients younger than 50 years (RR, 5.7; 95{\%} CI, 3.0 to 10.9 for four or more cups/d). The RR in patients who drank four or more cups of coffee per day and were current smokers was 8.1 (95{\%} CI, 5.1 to 13.0), suggesting an unfavorable effect on the combination of cigarette smoking and high coffee intake on the risk of AMI.",
keywords = "Case-control study, coffee, myocardial infarction, risk, smoking",
author = "Barbara D'Avanzo and {La Vecchia}, Carlo and Gianni Tognoni and Silvia Franceschi and {Grazia Franzosi}, Maria and Alessandro Nobili and Luigi Santoro and Giovanni Scarsi",
year = "1993",
doi = "10.1016/1047-2797(93)90081-E",
language = "English",
volume = "3",
pages = "595--600",
journal = "Annals of Epidemiology",
issn = "1047-2797",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Coffee consumption and risk of acute myocardial infarction in Italian males

AU - D'Avanzo, Barbara

AU - La Vecchia, Carlo

AU - Tognoni, Gianni

AU - Franceschi, Silvia

AU - Grazia Franzosi, Maria

AU - Nobili, Alessandro

AU - Santoro, Luigi

AU - Scarsi, Giovanni

PY - 1993

Y1 - 1993

N2 - The relationship between coffee consumption and acute myocardial infarction (AMI) was analyzed using data from a case-control study conducted in 1988 to 1989 within the framework of the GISSI-2 trial on streptokinase versus alteplase and heparin versus no heparin in the treatment of AMI. A total of 801 male patients with AMI and 792 control subjects who were hospitalized in several Italian regions for diseases unrelated to known or potential risk factors for cardiovascular diseases were included. Compared with coffee nondrinkers, the multivariate relative risks (RRs), after allowance for age, education, body mass index, smoking habits, alcohol consumption, family history of AMI, cholesterol level, history of diabetes, and hypertension, were 0.8 (95% confidence interval (CI), 0.5 to 1.2) for consumption of one cup/d, 1.3 (95% CI, 0.9 to 2.0) for two cups/d, 1.8 (95% CI, 1.1 to 2.7) for three cups, 2.5 (95% CI, 1.5 to 4.1) for four cups, and 2.6 (95% CI, 1.6 to 4.2) for five cups or more. The trend in risk with dose was statistically significant (P <0.001). Duration of coffee consumption was not associated with the risk of AMI. The RRs for daily coffee consumption were elevated across strata of various covariates, including age, smoking habits, cholesterol level, diabetes, and hypertension, with a particularly elevated (although not significantly heterogeneous) estimate in patients younger than 50 years (RR, 5.7; 95% CI, 3.0 to 10.9 for four or more cups/d). The RR in patients who drank four or more cups of coffee per day and were current smokers was 8.1 (95% CI, 5.1 to 13.0), suggesting an unfavorable effect on the combination of cigarette smoking and high coffee intake on the risk of AMI.

AB - The relationship between coffee consumption and acute myocardial infarction (AMI) was analyzed using data from a case-control study conducted in 1988 to 1989 within the framework of the GISSI-2 trial on streptokinase versus alteplase and heparin versus no heparin in the treatment of AMI. A total of 801 male patients with AMI and 792 control subjects who were hospitalized in several Italian regions for diseases unrelated to known or potential risk factors for cardiovascular diseases were included. Compared with coffee nondrinkers, the multivariate relative risks (RRs), after allowance for age, education, body mass index, smoking habits, alcohol consumption, family history of AMI, cholesterol level, history of diabetes, and hypertension, were 0.8 (95% confidence interval (CI), 0.5 to 1.2) for consumption of one cup/d, 1.3 (95% CI, 0.9 to 2.0) for two cups/d, 1.8 (95% CI, 1.1 to 2.7) for three cups, 2.5 (95% CI, 1.5 to 4.1) for four cups, and 2.6 (95% CI, 1.6 to 4.2) for five cups or more. The trend in risk with dose was statistically significant (P <0.001). Duration of coffee consumption was not associated with the risk of AMI. The RRs for daily coffee consumption were elevated across strata of various covariates, including age, smoking habits, cholesterol level, diabetes, and hypertension, with a particularly elevated (although not significantly heterogeneous) estimate in patients younger than 50 years (RR, 5.7; 95% CI, 3.0 to 10.9 for four or more cups/d). The RR in patients who drank four or more cups of coffee per day and were current smokers was 8.1 (95% CI, 5.1 to 13.0), suggesting an unfavorable effect on the combination of cigarette smoking and high coffee intake on the risk of AMI.

KW - Case-control study

KW - coffee

KW - myocardial infarction

KW - risk

KW - smoking

UR - http://www.scopus.com/inward/record.url?scp=0027764610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027764610&partnerID=8YFLogxK

U2 - 10.1016/1047-2797(93)90081-E

DO - 10.1016/1047-2797(93)90081-E

M3 - Article

C2 - 7921306

AN - SCOPUS:0027764610

VL - 3

SP - 595

EP - 600

JO - Annals of Epidemiology

JF - Annals of Epidemiology

SN - 1047-2797

IS - 6

ER -